Stockreport

Psyence Biomedical files to sell 10.9M common shares for holders. [Seeking Alpha]

Psyence Biomedical Ltd. - Ordinary Shares  (PBM) 
PDF Psyence Biomedical receives delisting determination from Nasdaq Psyence Biomedical to acquire drug developer Clairvoyant Financial information for Psyence Biomedica [Read more]